共 50 条
- [2] LEUKEMIA P388-TUMORS RESISTANT TO VINCRISTINE (P388/VCR), ADRIAMYCIN (P388/ADR), OR ARABINOSYLCYTOSINE (P388/ARA-C) - CROSS-RESISTANCE (P388/VCR AND P388/ADR) AND COLLATERAL SENSITIVITY (P388/ARA-C) TO HOMOHARRINGTONINE (H) (NSC 141633) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 199 - 199
- [4] Tyrosine and phenylalanine restriction sensitizes adriamycin-resistant P388 leukemia cells to adriamycin NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1996, 25 (01): : 47 - 60
- [5] INCREASED RADIATION SENSITIVITY OF P388 CELLS RESISTANT TO DOXORUBICIN (P388-ADR) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 258 - 258
- [7] CULTURED LEUKEMIA P388 CELLS RESISTANT TO VINCRISTINE (P388 VCR) OR TO ADRIAMYCIN (P388 ADR) - CROSS-RESISTANCE TO PUROMYCIN (NSC-3055), ACTINOMYCIN-D (NSC-3053), COLCHICINE (NSC-757), AND VINBLASTINE (NSC-49842) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 334 - 334
- [8] ENHANCED TRANSCRIPTION OF P-GLYCOPROTEIN GENE IN ADRIAMYCIN-RESISTANT P388 LEUKEMIA-CELLS CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1987, 10 (04): : B112 - B112
- [10] EFFECTS OF VINCRISTINE ON DAUNORUBICIN RETENTION BY RESISTANT P388 CELLS PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 357 - 357